Clinical trial
Kintampo Trial of Combination Therapy for Malaria
NCT00119145 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00119145 |
|---|---|
| Title | Kintampo Trial of Combination Therapy for Malaria |
| Official title | A Non-Inferiority, Open-Labelled, Randomised Trial Of The Efficacy And Safety Of Artesunate-Amodiaquine, Artemether-Lumefantrine, And Artesunate-Lapdap For Treatment Of Uncomplicated P. Falciparum Malaria Among Children In Ghana |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Kintampo Health Research Centre, Ghana |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | artesunate-amodiaquine, coartem, artesunate-lapdap |
| Enrollment | 510 |
| Start date | Jun 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Jul 13, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: